Vaccination of vulnerable patients can reduce infection-associated CV risks
28 Mar 2025
byProf. Timothy Tan, Westmead and Blacktown Hospitals, and Western Sydney University, Sydney, Australia
The elderly and patients with chronic conditions have increased susceptibility to viral infections such as herpes zoster (HZ) and respiratory syncytial virus (RSV), as well as higher risks of cardiovascular (CV) and other complications due to infection. At a recent symposium, Professor Timothy Tan of the Westmead and Blacktown Hospitals, and Western Sydney University, Sydney, Australia, shared insights on how the recombinant adjuvanted RSV vaccine (RSVPreF3) and recombinant zoster vaccine (RZV) can play an important role in preventing these infections, particularly in older individuals and those with comorbidities, thereby mitigating infection-associated risks.
